Underutilization of best systemic therapy in patients with metastatic prostate cancer.

被引：0
|
作者：
Roadman, Daniel
Cao, David
Vourganti, Srinivas
机构：
[1] Rush Univ, Med Ctr, Chicago, IL USA
[2] Graham Med Grp, Canton, IL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
111
引用
收藏
页数：1
相关论文
共 50 条
  • [1] UNDERUTILIZATION OF BEST SYSTEMIC THERAPY IN PATIENTS WITH METASTATIC PROSTATE CANCER: ASSESSMENT OF RACE AND SOCIOECONOMIC DISPARITIES
    Daniel, Roadman
    Srinivas, Vourganti
    David, Cao
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 : S14 - S14
  • [2] Heterogeneous bone response to systemic therapy (bisphosphonates and/or chemotherapy) in patients with metastatic prostate cancer.
    Roudier, MP
    True, LD
    Higano, CS
    Ott, SM
    Vessella, RL
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S122 - S123
  • [3] Endocrine therapy metastatic prostate cancer.
    Ruffion, A
    Fontaine, E
    Staerman, F
    PROGRES EN UROLOGIE, 2003, 13 (02): : 334 - 341
  • [4] Systemic therapy in metastatic prostate cancer
    Auclerc, G
    ANNALES D UROLOGIE, 2000, 34 (01) : 39 - 48
  • [5] Patients with metastatic prostate cancer. Recommendations for primary hormonal or chemohormonal therapy
    Ohlmann, C. -H.
    UROLOGE, 2017, 56 (11): : 1424 - 1429
  • [6] Docetaxel in older patients for metastatic prostate cancer.
    Mark, Frances May
    Pollard, Adam
    Thomson, Alastair H.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [7] Impact of advances in therapy on survival in patients with de novo metastatic prostate cancer.
    Adekolujo, Orimisan Samuel
    Akanbi, Maxwell Oluwole
    Wahab, Ahsan
    Mosalem, Osama
    Adekolujo, Oyebimpe O.
    Wang, Ling
    Hrinczenko, Borys
    Isaac, Dan
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E17052 - E17052
  • [8] Use of hormonal therapy in men with metastatic prostate cancer.
    Lu-Yao, GL
    Moore, DF
    Dipaola, RS
    Yao, SL
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 392S - 392S
  • [9] Multicenter population-level analysis of systemic therapy use in metastatic or recurrent prostate cancer.
    Mohamed, Heba
    Kim, Grace
    Macphail, Corin
    Bhuiyan, Ishmam
    Sidhu, Taylor
    Emami, Amir
    Huang, Longlong
    Sun, Shaun Zheng
    Tyldesley, Scott
    Ko, Jenny J.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [10] Utilization of next-generation sequencing and associated systemic therapy initiation in metastatic prostate cancer.
    Yang, Daniel X.
    Leapman, Michael
    Gross, Cary Philip
    Yu, James B.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345